Latest Articles

Publication Date
They labelled me an urban terrorist — I called it standing up for patients - AusDoc

They labelled me an urban terrorist — I called it standing up for patients AusDoc

Published: Sept. 18, 2025, 3:30 a.m.
Bayer Gets FDA Nod for Label Expansion of Kerendia in Heart Failure - The Globe and Mail

Bayer Gets FDA Nod for Label Expansion of Kerendia in Heart Failure The Globe and Mail

Published: July 14, 2025, 2:40 p.m.
Popular Sauce Recalled In Ohio Over Serious 'Labeling Error' - 100.7 WMMS

Popular Sauce Recalled In Ohio Over Serious 'Labeling Error' 100.7 WMMS

Published: April 2, 2025, 8:38 p.m.
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial - Medpage Today

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial Medpage Today

Published: Feb. 5, 2025, 5:54 p.m.
Robert Irwin Reacts to Being Labeled a Heartthrob by Fans in Thirsty Comments (Exclusive) - AOL

Robert Irwin Reacts to Being Labeled a Heartthrob by Fans in Thirsty Comments (Exclusive) AOL

Published: Jan. 5, 2025, 7:22 a.m.
FDA Expands Durvalumab Label to Endometrial Cancer - Medscape

FDA Expands Durvalumab Label to Endometrial Cancer Medscape

Published: June 17, 2024, 7 a.m.
Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial - The BMJ

Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial The BMJ

Published: May 15, 2024, 7 a.m.
GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data - BioSpace

GSK Builds Case for Broader Jemperli Label in Endometrial Cancer with Phase III Data BioSpace

Published: March 18, 2024, 7 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!